A BILL TO BE ENTITLED AN ACT RELATING TO HEALTH BENEFIT PLAN COVERAGE FOR ORALLY ADMINISTERED ANTICANCER DRUGS.
House committee substitute to the 1st edition makes the following changes.
Amends proposed GS 58-51-59.1 to require every policy or contract of accident or health insurance and every preferred provider benefit plan under GS 58-50-56 that provides coverage for prescribed, orally administered anticancer drugs that are used to kill or slow the growth of cancerous cells and that provides coverage for intravenously administered or injected anticancer drugs (was, that provides coverage for cancer treatment) must provide coverage for prescribed, orally administered anticancer drugs (was, orally administered anticancer drugs that are used to kill or slow the growth of cancerous cells) on a basis no less favorable than the coverage provided for the intravenously administered or injected anticancer drug. Also amends the statute to provide that nothing in the statute applies to accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, disability income, or other limited benefit health insurance policies.
© 2021 School of Government The University of North Carolina at Chapel Hill
This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.